Literature DB >> 21168017

Outcomes for endocarditis surgery in North America: a simplified risk scoring system.

Jeffrey G Gaca1, Shubin Sheng, Mani A Daneshmand, Sean O'Brien, J Scott Rankin, J Matthew Brennan, G Chad Hughes, Donald D Glower, James S Gammie, Peter K Smith.   

Abstract

OBJECTIVE: Operation for infective endocarditis is associated with the highest mortality of any valve disease, with overall rates of in-hospital mortality exceeding 20%. The Society of Thoracic Surgeons Adult Cardiac Surgery Database was examined to develop a simple risk scoring system and identify areas for quality improvement.
METHODS: From 2002 through 2008, 19,543 operations were performed for infective endocarditis. Logistic regression analysis related baseline characteristics to both operative mortality and a composite of mortality and major morbidity within 30 days. Points were assigned to each risk factor, and estimated risk was obtained by averaging events for all patients having the same number of points.
RESULTS: Overall unadjusted mortality was 8.2%, and complications occurred in 53%. Significant preoperative risk factors for mortality (associated points) were as follows: emergency, salvage status, or cardiogenic shock (17), preoperative hemodialysis, renal failure, or creatinine level less than 2.0 (12), preoperative inotropic or balloon pump support (10), active (vs treated) endocarditis (10), multiple valve involvement (9), insulin-dependent diabetes (8), arrhythmia (8), previous cardiac surgery (7), urgent status without cardiogenic shock (6), non-insulin-dependent diabetes (6), hypertension (5), and chronic lung disease (5), with a C statistic of 0.7578 (all P < .001). Risk-adjusted mortality and major morbidity were unchanged over the course of the study. In the entire data set, mortality was better if "any valve" was repaired (odds ratio = 0.76; P = .0023).
CONCLUSIONS: Operative mortality for surgically treated infective endocarditis is substantially lower than reported in-hospital mortality rates for infective endocarditis. The described risk scoring system will inform clinical decision-making in these complex patients. Published by Mosby, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21168017     DOI: 10.1016/j.jtcvs.2010.09.016

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  45 in total

1.  Surgical treatment of endocarditis: current status.

Authors:  Gosta B Pettersson
Journal:  Tex Heart Inst J       Date:  2011

2.  Risk of reoperative valve surgery for endocarditis associated with drug use.

Authors:  Makoto Mori; Syed Usman Bin Mahmood; Asher J Schranz; Ibrahim Sultan; Andrea L Axtell; Nadeen Sarsour; William Hiesinger; Marko T Boskovski; Sameer Hirji; Tsuyoshi Kaneko; Joseph Woo; Paul Tang; Arminder S Jassar; Pavan Atluri; Bryan A Whitson; Thomas Gleason; Arnar Geirsson
Journal:  J Thorac Cardiovasc Surg       Date:  2019-07-10       Impact factor: 5.209

3.  Effect of cerebral embolus size on the timing of cardiac surgery for infective endocarditis in patients with neurological complications.

Authors:  Yong Kyun Kim; Choong Gon Choi; Jiwon Jung; Shi Nae Yu; Ju Young Lee; Yong Pil Chong; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; Jun Hee Woo; Yang Soo Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-06       Impact factor: 3.267

4.  A risk factor analysis for in-hospital mortality after surgery for infective endocarditis and a proposal of a new predictive scoring system.

Authors:  Giuseppe Gatti; Bernardo Benussi; Florida Gripshi; Alessio Della Mattia; Alberto Proclemer; Antonio Cannatà; Lorella Dreas; Roberto Luzzati; Gianfranco Sinagra; Aniello Pappalardo
Journal:  Infection       Date:  2017-01-04       Impact factor: 3.553

5.  Tricuspid Valve Leaflet Repair and Augmentation for Infective Endocarditis.

Authors:  Alexander A Brescia; Tessa M F Watt; Aaron M Williams; Matthew A Romano; Steven F Bolling
Journal:  Oper Tech Thorac Cardiovasc Surg       Date:  2019-10-25

6.  Risk prediction in infective endocarditis by modified MELD-XI score.

Authors:  Peng-Cheng He; Xue-Biao Wei; Si-Ni Luo; Xiao-Lan Chen; Zu-Hui Ke; Dan-Qing Yu; Ji-Yan Chen; Yuan-Hui Liu; Ning Tan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-29       Impact factor: 3.267

7.  Marseille scoring system for empiric treatment of infective endocarditis.

Authors:  Frédérique Gouriet; Hervé Tissot-Dupont; Jean-Paul Casalta; Sandrine Hubert; Pierre-Edouard Fournier; Sophie Edouard; Alexis Theron; Hubert Lepidi; Dominique Grisoli; Gilbert Habib; Didier Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-02-03       Impact factor: 3.267

8.  Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure.

Authors:  Todd Kiefer; Lawrence Park; Christophe Tribouilloy; Claudia Cortes; Roberta Casillo; Vivian Chu; Francois Delahaye; Emanuele Durante-Mangoni; Jameela Edathodu; Carlos Falces; Mateja Logar; José M Miró; Christophe Naber; Marie Françoise Tripodi; David R Murdoch; Philippe Moreillon; Riccardo Utili; Andrew Wang
Journal:  JAMA       Date:  2011-11-23       Impact factor: 56.272

9.  Comparison of contemporary risk scores for predicting outcomes after surgery for active infective endocarditis.

Authors:  Tom Kai Ming Wang; Timothy Oh; Jamie Voss; Greg Gamble; Nicholas Kang; James Pemberton
Journal:  Heart Vessels       Date:  2014-01-25       Impact factor: 2.037

10.  Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors.

Authors:  Allan J Walkey; Melissa A Greiner; Susan R Heckbert; Paul N Jensen; Jonathan P Piccini; Moritz F Sinner; Lesley H Curtis; Emelia J Benjamin
Journal:  Am Heart J       Date:  2013-04-25       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.